| gene silencing by mirna | GO:0035195 | 10 | 0.986 | |
| chromatin organization | GO:0006325 | 206 | 0.984 | |
| dna metabolic process | GO:0006259 | 303 | 0.918 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.825 | Mouse |
| chromatin modification | GO:0016568 | 187 | 0.818 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.798 | Human |
| histone lysine methylation | GO:0034968 | 50 | 0.736 | |
| male meiosis i | GO:0007141 | 16 | 0.721 | Mouse |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.634 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.623 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.609 | |
| histone deubiquitination | GO:0016578 | 2 | 0.605 | |
| mrna processing | GO:0006397 | 63 | 0.603 | |
| nuclear division | GO:0000280 | 158 | 0.598 | Mouse |
| histone modification | GO:0016570 | 159 | 0.565 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.443 | |
| blastocyst growth | GO:0001832 | 23 | 0.442 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.435 | Mouse |
| histone methylation | GO:0016571 | 71 | 0.432 | |
| methylation | GO:0032259 | 134 | 0.419 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.416 | Human |
| stem cell fate specification | GO:0048866 | 3 | 0.405 | Worm |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.369 | |
| mrna metabolic process | GO:0016071 | 84 | 0.361 | |
| dna methylation | GO:0006306 | 43 | 0.361 | |
| nucleosome disassembly | GO:0006337 | 1 | 0.357 | |
| protein dna complex disassembly | GO:0032986 | 1 | 0.356 | |
| regulation of histone modification | GO:0031056 | 56 | 0.337 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.337 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.336 | |
| dna repair | GO:0006281 | 107 | 0.314 | |
| olfactory learning | GO:0008355 | 2 | 0.311 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.306 | |
| male gamete generation | GO:0048232 | 285 | 0.265 | Mouse |
| spermatogenesis | GO:0007283 | 284 | 0.261 | Mouse |
| lateral inhibition | GO:0046331 | 1 | 0.258 | |
| positive regulation of histone methylation | GO:0031062 | 16 | 0.251 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.248 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.243 | Human |
| regulation of chromatin modification | GO:1903308 | 57 | 0.236 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.229 | Human |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.227 | |
| stem cell differentiation | GO:0048863 | 268 | 0.218 | Worm |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.207 | |
| endocytosis | GO:0006897 | 168 | 0.205 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.204 | |
| chromatin remodeling | GO:0006338 | 32 | 0.203 | Human Mouse |
| protein methylation | GO:0006479 | 81 | 0.203 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.200 | Human |
| histone h4 k12 acetylation | GO:0043983 | 2 | 0.200 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.195 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.195 | |
| habituation | GO:0046959 | 3 | 0.188 | |
| axonogenesis | GO:0007409 | 274 | 0.186 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.186 | |
| macromolecule methylation | GO:0043414 | 120 | 0.185 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.183 | |
| regulation of nuclear transcribed mrna poly a tail shortening | GO:0060211 | 4 | 0.178 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.176 | |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 12 | 0.173 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.170 | |
| digestive system development | GO:0055123 | 200 | 0.169 | |
| germ cell development | GO:0007281 | 185 | 0.168 | |
| organelle fission | GO:0048285 | 170 | 0.164 | Mouse |
| lipid localization | GO:0010876 | 126 | 0.161 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.155 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.148 | |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.146 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.145 | Human |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.143 | Human |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.142 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.140 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.138 | Human |
| chromatin assembly or disassembly | GO:0006333 | 16 | 0.137 | |
| compound eye development | GO:0048749 | 1 | 0.136 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.135 | |
| segmentation | GO:0035282 | 93 | 0.131 | Fly |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.126 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.124 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.124 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.123 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.122 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.121 | |
| protein alkylation | GO:0008213 | 81 | 0.117 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.115 | Human |
| histone h4 acetylation | GO:0043967 | 10 | 0.111 | |
| immune effector process | GO:0002252 | 321 | 0.110 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.110 | |
| dna alkylation | GO:0006305 | 43 | 0.107 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.103 | |
| hypermethylation of cpg island | GO:0044027 | 3 | 0.103 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.101 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.099 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.097 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.097 | |
| dna methylation involved in gamete generation | GO:0043046 | 15 | 0.096 | |
| maintenance of location | GO:0051235 | 89 | 0.095 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.095 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.094 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.094 | |
| neuron projection guidance | GO:0097485 | 141 | 0.094 | |
| meiosis i | GO:0007127 | 60 | 0.093 | Mouse |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.093 | Human |
| chromatin disassembly | GO:0031498 | 1 | 0.092 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.091 | |
| blastocyst development | GO:0001824 | 80 | 0.091 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.090 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.088 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.088 | |
| chromatin silencing | GO:0006342 | 15 | 0.088 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.087 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.087 | |
| atp metabolic process | GO:0046034 | 75 | 0.085 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.085 | |
| gonad development | GO:0008406 | 141 | 0.085 | |
| amine metabolic process | GO:0009308 | 45 | 0.083 | |
| histone acetylation | GO:0016573 | 41 | 0.082 | |
| stem cell maintenance | GO:0019827 | 130 | 0.082 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.082 | Human |
| rhythmic process | GO:0048511 | 174 | 0.081 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.081 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.080 | |
| multicellular organism growth | GO:0035264 | 161 | 0.079 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.078 | Human |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.078 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.078 | |
| n terminal protein amino acid modification | GO:0031365 | 6 | 0.077 | |
| dna modification | GO:0006304 | 50 | 0.077 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.075 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.074 | Human |
| histone h3 k14 acetylation | GO:0044154 | 3 | 0.074 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.074 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.073 | |
| gene silencing by rna | GO:0031047 | 19 | 0.073 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.073 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.072 | |
| chromatin assembly | GO:0031497 | 13 | 0.072 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.070 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.070 | |
| rna catabolic process | GO:0006401 | 29 | 0.070 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.069 | |
| cognition | GO:0050890 | 149 | 0.069 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.069 | |
| learning or memory | GO:0007611 | 148 | 0.068 | |
| rna processing | GO:0006396 | 105 | 0.067 | Mouse |
| oogenesis | GO:0048477 | 56 | 0.067 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.066 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.065 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.065 | |
| muscle tissue development | GO:0060537 | 308 | 0.065 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.064 | |
| protein catabolic process | GO:0030163 | 221 | 0.064 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.063 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.062 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.062 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.061 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.060 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.059 | |
| pole plasm assembly | GO:0007315 | 2 | 0.059 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.059 | |
| circadian rhythm | GO:0007623 | 114 | 0.059 | |
| body morphogenesis | GO:0010171 | 45 | 0.059 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.058 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.058 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.058 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.058 | |
| gene silencing | GO:0016458 | 38 | 0.057 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.057 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.057 | |
| positive regulation of notch signaling pathway | GO:0045747 | 18 | 0.056 | |
| placenta development | GO:0001890 | 140 | 0.056 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.056 | |
| chemotaxis | GO:0006935 | 247 | 0.056 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.056 | |
| oxidation reduction process | GO:0055114 | 342 | 0.056 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.055 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.055 | Mouse |
| histone h3 k9 methylation | GO:0051567 | 17 | 0.055 | |
| cartilage development | GO:0051216 | 140 | 0.054 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.054 | Human |
| positive regulation of mrna 3 end processing | GO:0031442 | 5 | 0.054 | |
| regulation of mrna 3 end processing | GO:0031440 | 6 | 0.054 | |
| nucleosome positioning | GO:0016584 | 4 | 0.053 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.053 | |
| negative regulation of cell growth involved in cardiac muscle cell development | GO:0061052 | 2 | 0.053 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.053 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.052 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.052 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.051 | |
| heart morphogenesis | GO:0003007 | 178 | 0.051 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.051 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.050 | |
| female gamete generation | GO:0007292 | 74 | 0.049 | |
| skeletal system development | GO:0001501 | 356 | 0.049 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.049 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.049 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.049 | |
| epithalamus development | GO:0021538 | 2 | 0.049 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.049 | |
| embryonic placenta development | GO:0001892 | 98 | 0.049 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.048 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.047 | |
| phagocytosis | GO:0006909 | 66 | 0.047 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.047 | Mouse |
| germ line stem cell division | GO:0042078 | 2 | 0.046 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.046 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.046 | |
| regionalization | GO:0003002 | 337 | 0.045 | Fly |
| positive regulation of growth | GO:0045927 | 104 | 0.045 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.045 | |
| regulation of histone h3 k9 methylation | GO:0051570 | 8 | 0.045 | |
| mrna catabolic process | GO:0006402 | 22 | 0.045 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.045 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.044 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.044 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.044 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.044 | |
| positive regulation of mrna metabolic process | GO:1903313 | 17 | 0.044 | |
| organism emergence from protective structure | GO:0071684 | 4 | 0.044 | |
| negative regulation of gene silencing | GO:0060969 | 2 | 0.044 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.044 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.043 | Mouse |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.043 | |
| transcription from rna polymerase iii promoter | GO:0006383 | 3 | 0.043 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.042 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.042 | |
| rna splicing | GO:0008380 | 54 | 0.042 | Mouse |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.042 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.042 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.042 | |
| somitogenesis | GO:0001756 | 69 | 0.041 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.041 | |
| memory | GO:0007613 | 58 | 0.040 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.040 | |
| atp dependent chromatin remodeling | GO:0043044 | 9 | 0.040 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.040 | |
| regulation of organ growth | GO:0046620 | 61 | 0.040 | |
| protein modification by small protein removal | GO:0070646 | 21 | 0.039 | |
| cell division | GO:0051301 | 120 | 0.039 | |
| locomotory behavior | GO:0007626 | 195 | 0.038 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.038 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.038 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.038 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.038 | |
| organ growth | GO:0035265 | 117 | 0.038 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.037 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.037 | |
| gland development | GO:0048732 | 330 | 0.037 | |
| nuclear transcribed mrna catabolic process | GO:0000956 | 16 | 0.037 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.036 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.036 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.036 | |
| pre mirna processing | GO:0031054 | 3 | 0.036 | |
| positive regulation of binding | GO:0051099 | 49 | 0.036 | |
| digestive tract development | GO:0048565 | 190 | 0.036 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.036 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.036 | |
| male meiosis | GO:0007140 | 37 | 0.035 | Mouse |
| oocyte differentiation | GO:0009994 | 35 | 0.035 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.035 | |
| lung epithelium development | GO:0060428 | 37 | 0.035 | |
| atp catabolic process | GO:0006200 | 55 | 0.035 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.035 | |
| locomotor rhythm | GO:0045475 | 8 | 0.035 | |
| neuromuscular process | GO:0050905 | 99 | 0.034 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.034 | |
| organelle assembly | GO:0070925 | 177 | 0.034 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.034 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.033 | |
| positive regulation of mrna processing | GO:0050685 | 16 | 0.033 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.033 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.033 | |
| genitalia development | GO:0048806 | 37 | 0.033 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.033 | |
| oocyte construction | GO:0007308 | 2 | 0.033 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.033 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.033 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.033 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.032 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.032 | |
| response to sterol | GO:0036314 | 4 | 0.032 | |
| protein acylation | GO:0043543 | 64 | 0.032 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.032 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.032 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.032 | |
| cerebellar purkinje cell layer morphogenesis | GO:0021692 | 14 | 0.032 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.032 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.032 | |
| bone development | GO:0060348 | 120 | 0.031 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.031 | Human |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.031 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.031 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.031 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.031 | |
| rna interference | GO:0016246 | 2 | 0.030 | |
| lung development | GO:0030324 | 164 | 0.030 | |
| regulation of clathrin mediated endocytosis | GO:2000369 | 4 | 0.030 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.030 | |
| germ cell migration | GO:0008354 | 8 | 0.030 | |
| thick ascending limb development | GO:0072023 | 2 | 0.030 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.030 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.029 | |
| associative learning | GO:0008306 | 61 | 0.029 | |
| viral gene expression | GO:0019080 | 3 | 0.029 | |
| positive regulation of nuclear transcribed mrna poly a tail shortening | GO:0060213 | 4 | 0.029 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.029 | |
| positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:1900153 | 5 | 0.029 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.029 | |
| limb morphogenesis | GO:0035108 | 149 | 0.029 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.028 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.028 | |
| stem cell development | GO:0048864 | 219 | 0.028 | |
| glial cell differentiation | GO:0010001 | 131 | 0.028 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.028 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.028 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.028 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.028 | |
| organelle localization | GO:0051640 | 179 | 0.028 | |
| respiratory tube development | GO:0030323 | 167 | 0.027 | |
| regulation of cell motility | GO:2000145 | 236 | 0.027 | |
| cell adhesion | GO:0007155 | 329 | 0.027 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.027 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.027 | |
| b cell activation | GO:0042113 | 161 | 0.027 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.026 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.026 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.026 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.026 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.026 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.026 | |
| cell fate commitment | GO:0045165 | 210 | 0.026 | Worm |
| lymphocyte proliferation | GO:0046651 | 164 | 0.026 | |
| learning | GO:0007612 | 98 | 0.026 | |
| habenula development | GO:0021986 | 2 | 0.026 | |
| t cell differentiation | GO:0030217 | 174 | 0.026 | |
| septum primum development | GO:0003284 | 4 | 0.025 | |
| production of sirna involved in rna interference | GO:0030422 | 1 | 0.025 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.025 | |
| regulation of cell division | GO:0051302 | 76 | 0.025 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.025 | |
| dna hypermethylation | GO:0044026 | 3 | 0.025 | |
| trna wobble uridine modification | GO:0002098 | 2 | 0.025 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.025 | |
| lipid storage | GO:0019915 | 36 | 0.025 | |
| negative regulation of growth | GO:0045926 | 99 | 0.025 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.024 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.024 | |
| response to retinoic acid | GO:0032526 | 56 | 0.024 | |
| regulation of mrna catabolic process | GO:0061013 | 6 | 0.024 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.024 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.024 | |
| oocyte axis specification | GO:0007309 | 2 | 0.023 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.023 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.023 | |
| ear morphogenesis | GO:0042471 | 118 | 0.023 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.023 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.023 | |
| sister chromatid segregation | GO:0000819 | 20 | 0.023 | |
| rna 3 end processing | GO:0031123 | 20 | 0.023 | |
| nuclear transcribed mrna poly a tail shortening | GO:0000289 | 7 | 0.023 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.023 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.023 | |
| fat cell differentiation | GO:0045444 | 160 | 0.023 | |
| regulation of binding | GO:0051098 | 111 | 0.022 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.022 | |
| regulation of system process | GO:0044057 | 200 | 0.022 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.022 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.022 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.022 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.022 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.022 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.022 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.022 | Mouse |
| adult behavior | GO:0030534 | 135 | 0.022 | |
| regulation of protein localization | GO:0032880 | 231 | 0.022 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.022 | |
| neural tube development | GO:0021915 | 160 | 0.022 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.022 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.022 | |
| erbb signaling pathway | GO:0038127 | 32 | 0.021 | |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.021 | |
| forebrain development | GO:0030900 | 302 | 0.021 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.021 | |
| spermatid differentiation | GO:0048515 | 115 | 0.021 | |
| lung cell differentiation | GO:0060479 | 30 | 0.021 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.021 | |
| t cell proliferation | GO:0042098 | 120 | 0.021 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.021 | |
| regulation of neurological system process | GO:0031644 | 22 | 0.020 | |
| male germ line stem cell asymmetric division | GO:0048133 | 2 | 0.020 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.020 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.020 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.020 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.020 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.020 | |
| gastrulation | GO:0007369 | 116 | 0.020 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.020 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.020 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.020 | |
| positive regulation of mrna catabolic process | GO:0061014 | 5 | 0.020 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.020 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.020 | |
| exocytosis | GO:0006887 | 121 | 0.020 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.020 | |
| actin filament based movement | GO:0030048 | 23 | 0.020 | |
| response to oxidative stress | GO:0006979 | 123 | 0.020 | |
| response to acid chemical | GO:0001101 | 111 | 0.020 | |
| camera type eye development | GO:0043010 | 266 | 0.020 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.020 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.020 | |
| anion transport | GO:0006820 | 177 | 0.020 | |
| neuroblast fate determination | GO:0007400 | 1 | 0.019 | |
| actin cytoskeleton reorganization | GO:0031532 | 21 | 0.019 | |
| trna wobble base modification | GO:0002097 | 2 | 0.019 | |
| cardiac chamber development | GO:0003205 | 108 | 0.019 | |
| synaptic transmission | GO:0007268 | 329 | 0.019 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.019 | |
| synapse organization | GO:0050808 | 125 | 0.019 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.019 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.019 | |
| innate immune response | GO:0045087 | 157 | 0.019 | |
| regulation of microvillus organization | GO:0032530 | 3 | 0.019 | |
| sensory perception of sound | GO:0007605 | 97 | 0.019 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.019 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.019 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.019 | |
| cohesin localization to chromatin | GO:0071921 | 1 | 0.019 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.019 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.019 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.019 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.018 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.018 | |
| midgut development | GO:0007494 | 4 | 0.018 | |
| positive regulation of gene silencing by mirna | GO:2000637 | 1 | 0.018 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.018 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.018 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.018 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.018 | |
| cell proliferation involved in heart valve morphogenesis | GO:0003249 | 1 | 0.018 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.018 | |
| molting cycle | GO:0042303 | 90 | 0.018 | |
| negative regulation of platelet derived growth factor receptor beta signaling pathway | GO:2000587 | 2 | 0.018 | |
| negative regulation of mrna processing | GO:0050686 | 12 | 0.018 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.018 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.018 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 29 | 0.018 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.018 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.018 | |
| ear development | GO:0043583 | 200 | 0.018 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.018 | |
| physiological cardiac muscle hypertrophy | GO:0003301 | 3 | 0.018 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.018 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.017 | |
| somite development | GO:0061053 | 81 | 0.017 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.017 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.017 | |
| dna dependent dna replication | GO:0006261 | 24 | 0.017 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.017 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.017 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.017 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.017 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.017 | |
| histone h4 k20 methylation | GO:0034770 | 8 | 0.017 | |
| transcription from rna polymerase i promoter | GO:0006360 | 13 | 0.017 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.017 | Worm |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.017 | Human |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.017 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.017 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 8 | 0.017 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.016 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.016 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.016 | |
| embryonic camera type eye development | GO:0031076 | 36 | 0.016 | |
| metanephric distal convoluted tubule development | GO:0072221 | 5 | 0.016 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.016 | |
| cell recognition | GO:0008037 | 83 | 0.016 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.016 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 45 | 0.016 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.016 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.016 | |
| ossification | GO:0001503 | 216 | 0.016 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.016 | |
| cellular homeostasis | GO:0019725 | 240 | 0.016 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.016 | |
| epithelial tube formation | GO:0072175 | 130 | 0.016 | |
| neural tube closure | GO:0001843 | 90 | 0.016 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 26 | 0.016 | |
| mrna transcription | GO:0009299 | 4 | 0.016 | |
| regulation of protein processing | GO:0070613 | 96 | 0.016 | |
| protein ubiquitination | GO:0016567 | 171 | 0.016 | |
| positive regulation of protein binding | GO:0032092 | 29 | 0.016 | |
